BIOXCEL THERAPEUTICS INC (BTAI) Institutional Ownership and Insiders Activity

BIOXCEL THERAPEUTICS INC (BTAI) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $323,193 based on SEC Form 13F filings for the quarter ended March 31, 2026.

Oaktree Capital Management is the largest disclosed holder, reporting approximately $323,193 in BTAI holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Oaktree Capital Management representing the majority of disclosed value.